학술논문
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study
Document Type
Article
Author
Source
In: Thyroid . (Thyroid, 1 March 2024, 34(3):347-359)
Subject
Language
English
ISSN
15579077
10507256
10507256